CAB Steering Group Feedback Mark McPherson. What, why and who… What: A representative group of...
-
Upload
anthony-king -
Category
Documents
-
view
220 -
download
0
description
Transcript of CAB Steering Group Feedback Mark McPherson. What, why and who… What: A representative group of...
CAB Steering Group Feedback
Mark McPherson
What, why and who… What: A representative group of people from
within the CAB with an interest in the future of this group
Why: To increase the number of people involved in preparing this meeting, reducing work for some and adding difference perspectives
Who: At the moment we are: Ben Cromarty, Robert James, Carmen Tarrades, Brian West….also with us in spirit were Badru Male and Fiona Pettitt
What did we do?
Looked at what the CAB has done to date
Discussed its strengths
Looked for opportunities
Planned this meeting
What do we want to do today
Feedback what we did
Get ideas for future events
Get ideas about the future role
Get ideas about how the group should be run
Aims of the UK CAB
To provide a specialist treatment training programme 3 speakers and a network sessions Speakers include researchers and companies as
well as group members To strengthen the network of treatment
workers and advocates Discussing issues and advances Community representation (eg BHIVA guidelines)
What has the CAB been up to? Established in 2002 This is the 15th meeting Past meetings have included: Trail Design;
Resistance and Salvage Therapy; Pregnancy, Fertility and Sperm Washing; Access to Services for Refugees and Asylum Seekers; Statistics; Immunology and Children
They have been delivered in the style of meetings and training events
We have an active web based discussions group
How do we compare?
ECAB - more focused on drug trial design and linkage to the pharmaceutical industry
French and German CABs - more activist based in a traditional sense involved with demonstrations etc.
Strengths Diverse and Representative
Delivers accessible information - without oversimplifying it.
Provides contact nationally (often where treatment maybe sub-optimal)
Affords community involvement in other policy forums
Opportunities Increase involvement in trials
Seek greater representation (pro-actively seeking key players to attend)
Create clearer policy lines and actions based on e-mail discussion
Be pro-active in the development of patient involvement across all Strategic Health Authority Regions
Take a view and lobby on issues regarding standard of care delivery as well as treatment efficacy
What we will do next?
Have another steering group meeting after this one to plan the next CAB
Plan how to take forward your feedback
Look at how the next steering group should be formed
Key Questions
Have you ideas for future events?
Have you ideas about the future role?
Have you ideas about how the group should be run?